Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease

被引:54
|
作者
Roberts, T. J.
Price, J.
Williams, S. C. R.
Modo, M.
机构
[1] Kings Coll London, Neuroimaging Res Grp P042, Dept Neurol, Inst Psychiat, London SE5 8AF, England
[2] Kings Coll London, Dept Neurosci, Inst Psychiat, London SE5 8AF, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
Huntington's disease; MRI; stem cell; functional recovery; surrogate marker; animal model;
D O I
10.1016/j.neuroscience.2006.01.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
tCell replacement has the potential to become a frontline therapy to remedy behavioral impairments in Huntington's disease. To determine the efficacy of stem cell transplantation, behavioral assessment and in vivo monitoring of the lesion environment are paramount. We here demonstrate that neural stem cells from the MHP36 cell line prevented the development of a deficit on the beam walk test while providing partial recovery of learning in the water maze. However, no beneficial effect on rats' impairment in the staircase test was observed. By quantification of the lesion from serial magnetic resonance images, no effect of neural stem cells on lesion volume was observed. Instead, a preservation of striatal volume over time and its correlation with performance on the beam walk test suggested that sparing of behavioral function was associated with a stagnation of ongoing tissue loss rather than a reduction in lesion size. Serial imaging therefore warrants further implementation in clinical trials of neural grafts to monitor in vivo changes in the damaged brain due to transplantation. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1187 / 1199
页数:13
相关论文
共 50 条
  • [31] Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease
    Dey, Nicholas D.
    Bombard, Matthew C.
    Roland, Bartholomew P.
    Davidson, Stacy
    Lu, Ming
    Rossignol, Julien
    Sandstrom, Michael I.
    Skeel, Reid L.
    Lescaudron, Laurent
    Dunbar, Gary L.
    BEHAVIOURAL BRAIN RESEARCH, 2010, 214 (02) : 193 - 200
  • [32] Intrastriatal Transplantation of Adenovirus-Generated Induced Pluripotent Stem Cells for Treating Neuropathological and Functional Deficits in a Rodent Model of Huntington's Disease
    Fink, Kyle D.
    Crane, Andrew T.
    Leveque, Xavier
    Dues, Dylan J.
    Huffman, Lucas D.
    Moore, Allison C.
    Story, Darren T.
    DeJonge, Rachel E.
    Antcliff, Aaron
    Starski, Phillip A.
    Lu, Ming
    Lescaudron, Laurent
    Rossignol, Julien
    Dunbar, Gary L.
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (05) : 620 - 631
  • [33] Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease
    Buren, Caodu
    Parsons, Matthew P.
    Smith-Dijak, Amy
    Raymond, Lynn A.
    NEUROBIOLOGY OF DISEASE, 2016, 87 : 80 - 90
  • [34] Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease
    Reynolds, DS
    Carter, RJ
    Morton, AJ
    JOURNAL OF NEUROSCIENCE, 1998, 18 (23): : 10116 - 10127
  • [35] In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease
    Jackson, Johanna
    Chapon, Catherine
    Jones, William
    Hirani, Ella
    Qassim, Abdullah
    Bhakoo, Kishore
    JOURNAL OF NEUROSCIENCE METHODS, 2009, 183 (02) : 141 - 148
  • [36] Silymarin ameliorates motor function and averts neuroinflammation-induced cell death in the rat model of Huntington's disease
    Aliaghaei, Abbas
    Meftahi, Gholam Hossein
    BRAIN RESEARCH BULLETIN, 2024, 216
  • [37] Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease
    Ramaswamy, Shilpa
    McBride, Jodi L.
    Herzog, Christopher D.
    Brandon, Eugene
    Gasmi, Mehdi
    Bartus, Raymond T.
    Kordower, Jeffrey H.
    NEUROBIOLOGY OF DISEASE, 2007, 26 (02) : 375 - 384
  • [38] Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease
    Gianfriddo, M
    Corsi, C
    Melani, A
    Pèzzola, A
    Reggio, R
    Popoli, P
    Pedata, F
    BRAIN RESEARCH, 2003, 979 (1-2) : 225 - 229
  • [39] GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease
    Wang, F.
    Kameda, M.
    Yasuhara, T.
    Tajiri, N.
    Kikuchi, Y.
    Liang, H. B.
    Tayra, J. T.
    Shinko, A.
    Wakamori, T.
    Agari, T.
    Date, I.
    NEUROSCIENCE RESEARCH, 2011, 71 (01) : 92 - 98
  • [40] Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology
    Choudhury, Kamalika Roy
    Das, Srijit
    Bhattacharyya, Nitai P.
    JOURNAL OF PROTEOMICS, 2016, 132 : 155 - 166